Recently obtained corporate documents show that Syngenta and its predecessor corporate entities had been discussing the safety of its Gramoxone paraquat-based products and suggest that the company resisted changes to the product formulation in an effort to protect profits, the Guardian reports.
Documents Show Syngenta Knew of Gramaxone Safety Issues
Blog Topics
Are you looking for data-driven marketing for your law firm?
As a full-service agency, CAMG handles everything from marketing and creative to the support your law firm needs to operate campaigns at the maximum efficiency.
THE NATION’S LARGEST FULLY INTEGRATED
Marketing Agency Dedicated to Law Firms
- Television
- Radio
- Public Relations
- Medical Record Retrieval & Review
- Search Engine Optimization
- Paid Digital
- Out of Home
- Intake & Contracting Services